Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography.
In a study population consisting of healthy men (n = 8), women not using oral contraceptives (OC) (n = 28) and women using different kinds of OC (n = 187) we used calibrated automated thrombography (CAT) in the absence and presence of added activated protein C (APC) to compare parameters that can be obtained from thrombin generation curves, i.e. lag time, time to peak, peak height and endogenous thrombin potential (ETP). Both with and without APC, plasmas of OC users exhibited the shortest lag time and time to peak, and the highest peak height and ETP. In the absence of APC none of these parameters differed between users of OC containing different progestogens. In contrast, in the presence of APC shorter lag times and time to peak, and higher peak height and ETP were observed in plasma of users of gestodene-, desogestrel-, drospirenone- and cyproterone acetate-containing OC than in plasma of users of levonorgestrel- containing OC. The ETP determined in the absence of APC (ETP(-APC)) had no predictive value for the APCsr (r = 0.11; slope 0.9 x 10(-3); 95% CI: -0.1 x 10(-3) to 2.0 x 10(-3)) whereas the ETP measured in the presence of APC (ETP+APC) showed an excellent correlation with the APCsr (r = 0.95; slope 6.6 x 10(-3); 95% CI: 6.3 x 10(-3) to 6.9 x 10(-3)) indicating that the APCsr is entirely determined by the ETP+APC. In conclusion, OC use increases thrombin generation, but differential effects of second and third generation OCs on the protein C system likely determine the differences in the risk of venous thrombosis between these kinds of OC.
Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Svetlana N
SN
Tchaikovski
Huib A A M
HA
van Vliet
M C L G D
MC
Thomassen
Rogier M
RM
Bertina
Frits R
FR
Rosendaal
Per-Morten
PM
Sandset
Frans M
FM
Helmerhorst
Guido
G
Tans
Jan
J
Rosing
D020016:Activated Protein C Resistance / Q000097:blood / Q000139:chemically induced*; D000328:Adult; D001331:Automation; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests / Q000379:methods* / Q000592:standards; D002138:Calibration; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D011486:Protein C / Q000378:metabolism; D015203:Reproducibility of Results; D018570:Risk Assessment; D013917:Thrombin / Q000378:metabolism*; D013997:Time Factors; D020246:Venous Thrombosis / Q000097:blood / Q000139:chemically induced*
D003278:Contraceptives, Oral, Hormonal; D011486:Protein C; D013917:Thrombin